Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA |
|---|
| Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
MO MOH MOLINA HEALTHCARE, INC. FY ended Feb 06, 2026 | $198.39 | $10.36B | $11.72B | $45.43B | $796.00M | $472.00M | 22.24x | 0.23x | 11.95x |
HU HUM HUMANA INC FY ended Jan 31, 2026 | $390.90 | $46.93B | $48.38B | $129.66B | $2.76B | $1.19B | 39.73x | 0.36x | 12.34x |
UN UNH UNITEDHEALTH GROUP INC FY ended Feb 20, 2026 | $394.74 | $354.32B | $432.43B | $447.57B | $20.65B | $12.06B | 29.84x | 0.79x | 16.39x |
OS OSCR Oscar Health, Inc. FY ended Dec 31, 2025 | $31.08 | $9.33B | $10.54B | $11.70B | -$412.94M | -$443.15M | -18.39x | 0.80x | — |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 17.57x | 3/4 | -$99.35B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 0.54x | 4/4 | $106.10B | $214.78 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 18.35x | 4/4 | -$122.49B | — | Target fundamentals do not produce a usable positive equity value. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
MO MOH MOLINA HEALTHCARE, INC. FY ended Feb 06, 2026 | $198.39 | $10.36B | $11.72B | $45.43B | $796.00M | $472.00M | 22.24x | 0.23x | 11.95x |
HU HUM HUMANA INC FY ended Jan 31, 2026 | $390.90 | $46.93B | $48.38B | $129.66B | $2.76B | $1.19B | 39.73x | 0.36x | 12.34x |
UN UNH UNITEDHEALTH GROUP INC FY ended Feb 20, 2026 | $394.74 | $354.32B | $432.43B | $447.57B | $20.65B | $12.06B | 29.84x | 0.79x | 16.39x |
OS OSCR Oscar Health, Inc. FY ended Dec 31, 2025 | $31.08 | $9.33B | $10.54B | $11.70B | -$412.94M | -$443.15M | -18.39x | 0.80x | — |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 17.57x | 3/4 | -$99.35B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 0.54x | 4/4 | $106.10B | $214.78 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 18.35x | 4/4 | -$122.49B | — | Target fundamentals do not produce a usable positive equity value. |
